TScan Therapeutics, Inc. (TCRX) Marketable Securities, Current USD 2023 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
TScan Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from 2023 to 2024.
  • TScan Therapeutics, Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $22.3 M.
Marketable Securities, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $22.3 M Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $58.7 M Dec 31, 2023 10-Q 2024-05-13
Q3 2023 $60.2 M Sep 30, 2023 10-Q 2023-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.